Australian Patent Office today accepted a patent for methods of synthesis for cannadibiol and analogues, and will begin a search of international patents to determine whether the process is a first.

Standardised pharmaceutical CBD is fast becoming the preferred option for medical applications, with doctors hesitant to recommend hemp products after federal regulators and consumer watchdogs reporting that pesticides and environmental toxins are often concentrated in CBD from hemp farms.